Association of Antiosteoporotic Medication Bisphosphonates and Denosumab with Primary Breast Cancer: An Electronic Health Record Cohort Study
Background: The risks of osteoporosis and breast cancer are increasing in elderly women. Bisphosphonates and denosumab are recommended for treatment of osteoporosis. They have different and overlapping pharmacodynamics and previous studies have shown conflicting results regarding their risk associat...
Saved in:
Main Authors: | Alexander Stanoyevitch (Author), Lei Zhang (Author), Javier Sanz (Author), Robert W. Follett (Author), Douglas S. Bell (Author) |
---|---|
Format: | Book |
Published: |
Mary Ann Liebert,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Denosumab, teriparatide and bisphosphonates for glucocorticoid-induced osteoporosis: a Bayesian network meta-analysis
by: Liang Dong, et al.
Published: (2024) -
Case series: Osteonecrosis of the jaw related to denosumab preceded by bisphosphonates in cancer and osteoporotic patients
by: Devie Falinda, et al.
Published: (2022) -
Dental implants in oral rehabilitation after denosumab and bisphosphonate-related osteonecrosis of the jaw in a young patient: an unusual case
by: Salabert Noémie, et al.
Published: (2024) -
Analysis of utilization of bisphosphonates, strontium ranelate and denosumabe in Serbia, Finland, Norway and Denmark in the period 2013-2016
by: Cvjetković Đurđa M., et al.
Published: (2019) -
Variation in Antiosteoporotic Drug Prescribing and Spending Across Spain. A Population-Based Ecological Cross-Sectional Study
by: Gabriel Sanfélix-Gimeno, et al.
Published: (2018)